CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine.
Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
精氨酸包覆策略的简便性彰显了免疫刺激性 OMV 的多功能性,可广泛用于个性化细菌免疫治疗应用。
基于细菌的癌症治疗已展示出对抗肿瘤的创新策略。近期研究聚焦于革兰氏阴性菌外膜囊泡(OMVs)作为一种新型癌症免疫治疗策略,因其作为多功能载体的固有特性。
在此,我们开发了一种展示人乳头瘤病毒(HPV)相关E7抗原的沙门氏菌来源OMV疫苗,利用聚(L-精氨酸)细胞穿透肽(CPP)增强HPV16 E7(aa49-67)H-2 Db与OMV的亲和力,命名为SOMV-9RE7。
由于OMV固有的免疫原性特性,SOMV-9RE7通过抗原呈递细胞摄取和抗原交叉呈递有效激活适应性免疫。接种工程化OMV显示出即时肿瘤抑制和肿瘤反应性浸润免疫细胞的募集。
Bacteria-based cancer therapy have demonstrated innovative strategies to combat tumors. Recent studies have focused on gram-negative bacterial outer membrane vesicles (OMVs) as a novel cancer immunotherapy strategy due to its intrinsic properties as a versatile carrier. METHOD: Here, we developed an Human Papillomavirus (HPV)-associated E7 antigen displaying Salmonella-derived OMV vaccine, utilizing a Poly(L-arginine) cell penetrating peptide (CPP) to enhance HPV16 E7 (aa49-67) H-2 Db and OMV affinity, termed SOMV-9RE7.
Due to OMV's intrinsic immunogenic properties, SOMV-9RE7 effectively activates adaptive immunity through antigen-presenting cell uptake and antigen cross-presentation. Vaccination of engineered OMVs shows immediate tumor suppression and recruitment of infiltrating tumor-reactive immune cells.
The simplicity of the arginine coating strategy boasts the versatility of immuno-stimulating OMVs that can be broadly implemented to personalized bacterial immunotherapeutic applications.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。